— Know what they know.
Not Investment Advice

WHWK NASDAQ

Whitehawk Therapeutics Inc
1W: -11.2% 1M: -12.7% 3M: +1.2% YTD: +68.4% 1Y: +129.6% 3Y: -22.7% 5Y: -85.5%
$4.11
+0.04 (+0.98%)
 
Weekly Expected Move ±7.0%
$4 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $234.3M mcap · 24M float · 1.94% daily turnover · Short 42% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$234.3M
52W Range1.8-5.495
Volume283,517
Avg Volume458,889
Beta0.81
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEODavid J. Lennon
Employees32
SectorHealthcare
IndustryBiotechnology
IPO Date2017-08-01
2 Headquarters Plaza
Morristown, NJ 07960
US
551 321 2234
About Whitehawk Therapeutics Inc

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Recent Insider Trades

NameTypeSharesPriceDate
Iyengar Vijay K A-Award 76,080 $4.19 2026-09-09
Iyengar Vijay K 0 2026-09-09
Dalal Anupam A-Award 38,040 $4.16 2026-06-12
Zhao Baiteng A-Award 38,040 $4.16 2026-06-12
Reeve Emma A-Award 38,040 $4.16 2026-06-12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms